Cargando…
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
INTRODUCTION: The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic problem. The lung is the major target organ of SARS‐CoV‐2 and some of its variants like Delta and Omicron variant adapted i...
Autores principales: | Verma, Geetika, Dhawan, Manish, Saied, AbdulRahman A., Kaur, Geetika, Kumar, Reetesh, Emran, Talha Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521379/ https://www.ncbi.nlm.nih.gov/pubmed/37773723 http://dx.doi.org/10.1002/iid3.1020 |
Ejemplares similares
-
Variability of severe acute respiratory syndrome coronavirus 2 infection in children and adults
por: Verma, Geetika, et al.
Publicado: (2023) -
Emergence of omicron variant's sublineages BA.4 and BA.5: risks assessment and possible countermeasures
por: Dhawan, Manish, et al.
Publicado: (2022) -
Double-edged sword.
Publicado: (1994) -
Immunomodulatory effects of zinc and its impact on COVID-19 severity
por: Dhawan, Manish, et al.
Publicado: (2022) -
Respiratory viruses and the inflammasome: The double-edged sword of inflammation
por: Waldstein, Kody A., et al.
Publicado: (2022)